# Elion Therapeutics, Inc. — Form D

Elion Therapeutics, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2024-06-26. The offering totals $83.8M, of which $25.4M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2024-06-26
- Form: D
- Accession: 0002028346-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $83.8M
- Amount sold: $25.4M
- Remaining: $58.4M
- Investors: 6
- Date of first sale: 2024-06-11
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-516941

## Issuer

- Name: Elion Therapeutics, Inc.
- CIK: 0002028346
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: C/O DEERFIELD MANAGEMENT COMPANY LP, NEW YORK, NY, 10010
- Phone: 212-551-1600

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Jim Flynn | Director | New York, NY |
| Martin Heidecker | Director | Cambridge, MA |
| Jonathan Leff | Director | Ness Ziona, L3 |
| Kieren Marr | Director | Baltimore, MD |
| Kieren Marr | Executive Officer | Baltimore, MD |

## More

- [CIK 2028346 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2028346&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002028346-24-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.